Gian Life Care Limited

BSE: 542918
Gian Life Care Limited - healthcare in Kanpur, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN L85100UP2018PLC110119 Incorporated 06 November 2018 ROC Uttar Pradesh HQ Kanpur, Uttar Pradesh, India
Active Listed - BSE: 542918 Public Limited Company healthcare
Data last updated
Market Cap
₹4.34 Cr
GIANLIFE · BSE
Share Price
₹4.24
+0.95% today
Revenue
₹6.63 Cr
FY 2024-25 · -49.5% YoY
EBITDA
₹0.95 Cr
Margin 14.3%
Net Profit
−₹0.05 Cr
FY 2024-25 · -101.2% YoY
ROE
-0.2%
ROCE 2.3%
Debt / Equity
0.28
Interest cover 171.9x
Authorised capital
₹12 Cr
Registered with MCA

About Gian Life Care Limited

Data last updated:

Gian Life Care Limited is a public limited company based in Kanpur, Uttar Pradesh, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 06 November 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN L85100UP2018PLC110119. It is a listed company as per MCA records. Its shares are listed on BSE: 542918.

The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹10.34 Cr. It is led by directors including Arun Kumar Gupta (Managing Director) and Rashika Agarwal.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 7/216 (6) Swaroop Nagar, Kanpur, Uttar Pradesh, India – 208002.

As per the latest consolidated financials for FY 2024-25, the company reported a revenue of ₹6.63 Cr, a decline of 49.5% compared to the previous year. For the same year it recorded a net loss of ₹5 Lakh (net margin -0.8%) and EBITDA of ₹95 Lakh (EBITDA margin 14.3%). The net worth stands at ₹19.23 Cr (down 0.2% YoY). Total assets are valued at ₹25.99 Cr (up 3.9% YoY).

The company has about 23 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Gian Lifecare. As per MCA filings, the company has open charges of ₹3.88 Cr on record. Court records list 26 cases involving the company, including 2 filed by the company and 24 filed against it; 8 cases are pending. The company has 87 deals on record (86 market trades, 1 ipo); the latest was in March 2026.

For more details, the company can be reached via its website gianpathlabs.com.

Company details

CIN L85100UP2018PLC110119
Registration Number 110119
Incorporation Date 06 November 2018
ROC Uttar Pradesh
Listing Status Listed - Listed on BSE (542918)
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023

CIN history

Gian Life Care has one previous CIN (Corporate Identification Number): U85100UP2018PLC110119. The current CIN is L85100UP2018PLC110119, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85100UP2018PLC110119Current
U85100UP2018PLC110119Previous
Key People
Arun Kumar Gupta Managing Director Rashika Agarwal Director Abhiram Saran Agarwal Additional Director

Contact details

Gian Life Care Limited's registered office is in Kanpur, Uttar Pradesh. Its website is gianpathlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    gianpathlabs.com
  • Registered Address
    7/216 (6) Swaroop Nagar, Kanpur, Uttar Pradesh, India – 208002
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Gian Life Care Limited, buy the company report.

Comprehensive company report
Gian Life Care Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Gian Life Care operates one associated brand: Gian Lifecare. Each brand links to its own profile.

BrandDescriptionWebsite
Gian Lifecare
Pathology testing and laboratory services in India.gianpathlabs.com

Business activity

The main business activity of Gian Life Care is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ2Medical and dental practice, Nursing, pathology, blood bank services, etc.

To see the full business activity and turnover split of Gian Life Care Limited, buy the company report.

Financials of Gian Life Care Limited

FY 2024-25 filings available

Gian Life Care Limited reported revenue of ₹6.63 Cr (down 49.5% YoY) for FY 2024-25.

Financial Highlights

FY 2024-25 · Consolidated
Revenue
₹6.63 Cr
-49.5% YoY
EBITDA
₹0.95 Cr
-84.5% YoY
Profit After Tax
−₹0.05 Cr
-101.2% YoY
Net Worth
₹19.23 Cr
-0.2% YoY
Total Assets
₹25.99 Cr
+3.9% YoY
Total Debt
₹5.84 Cr
+19.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue6.6313.1211.9215.93
Revenue growth-49.5%+10.1%-25.2%-
EBITDA0.956.141.846.07
EBITDA margin+14.3%+46.8%+15.4%+38.1%
Profit before tax0.035.741.585.86
Net profit(0.05)4.151.054.38
Net profit margin-0.8%+31.6%+8.8%+27.5%
EPS (₹)(0.04)4.021.034.23
Balance sheet
Total assets25.9925.0220.2316.13
Net worth19.2319.2715.1214.03
Total debt5.844.884.572.03
Cash & bank6.965.995.774.85
Net working capital8.485.733.653.68
Cash flow
Cash from operations0.270.702.225.79
Cash from investing0.25(0.32)(0.94)(4.12)
Cash from financing0.45(0.16)(0.37)0.67
ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue1.120.660.871.111.591.951.984.60
Revenue growth (YoY)-29.6%-66.2%-56.1%-75.9%-58.1%---
Other income0.090.090.15(0.24)0.160.170.190.18
EBITDA0.24(0.41)0.14(0.01)0.480.220.223.04
EBITDA margin+21.4%-62.1%+16.1%-0.9%+30.2%+11.3%+11.1%+66.1%
Depreciation0.110.110.110.270.120.120.120.11
Interest0.150.120.090.130.120.120.140.10
Profit before tax0.07(0.55)0.09(0.65)0.400.150.153.01
Tax(0.03)(0.04)0.03(0.05)0.040.020.060.89
Net profit0.10(0.51)0.06(0.60)0.360.130.092.12
EPS (₹)0.10(0.50)0.05(0.59)0.340.120.092.07
MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income statement
Revenue6.6313.1211.9215.9310.467.650.56
Revenue growth-49.5%+10.1%-25.2%+52.3%+36.7%+1266.1%-
EBITDA0.956.202.046.073.112.090.19
EBITDA margin+14.3%+47.3%+17.1%+38.1%+29.7%+27.3%+33.9%
Profit before tax0.305.911.785.862.761.560.13
Net profit0.164.301.254.382.021.120.10
Net profit margin+2.4%+32.8%+10.5%+27.5%+19.3%+14.6%+17.9%
EPS (₹)0.154.151.224.234.292.40240.96
Balance sheet
Total assets25.7524.6520.4216.1410.668.731.46
Net worth19.7619.6115.3114.039.667.640.11
Total debt5.074.174.572.031.001.091.36
Cash & bank6.955.975.754.742.511.131.10
Net working capital8.695.923.663.571.370.63(2.94)
Cash flow
Cash from operations0.250.752.325.792.871.512.99
Cash from investing0.230.33(0.94)(4.23)(1.10)(3.96)(2.92)
Cash from financing0.49(0.86)(0.37)0.67(0.39)2.550.96
ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue1.120.660.871.111.591.951.984.60
Revenue growth (YoY)-29.6%-66.2%-56.1%-75.9%-58.1%---
Other income0.090.090.15(0.24)0.160.160.170.18
Total expenses0.871.050.731.111.111.721.761.50
EBITDA0.25(0.39)0.140.000.480.230.223.10
EBITDA margin+22.3%-59.1%+16.1%0.0%+30.2%+11.8%+11.1%+67.4%
Depreciation0.110.110.110.110.120.120.120.07
Interest0.130.090.090.100.100.100.110.11
Profit before tax0.10(0.50)0.09(0.45)0.420.170.163.10
Tax(0.03)(0.04)0.030.020.040.020.060.91

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 29 Oct 2026
ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue1.120.660.871.111.591.951.984.60
Revenue growth (YoY)-29.6%-66.2%-56.1%-75.9%-58.1%---
Other income0.090.090.15(0.24)0.160.170.190.18
EBITDA0.24(0.41)0.14(0.01)0.480.220.223.04
EBITDA margin+21.4%-62.1%+16.1%-0.9%+30.2%+11.3%+11.1%+66.1%
Depreciation0.110.110.110.270.120.120.120.11
Interest0.150.120.090.130.120.120.140.10
Profit before tax0.07(0.55)0.09(0.65)0.400.150.153.01
Tax(0.03)(0.04)0.03(0.05)0.040.020.060.89
Net profit0.10(0.51)0.06(0.60)0.360.130.092.12
EPS (₹)0.10(0.50)0.05(0.59)0.340.120.092.07
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue6.6313.1211.9215.93
Revenue growth-49.5%+10.1%-25.2%-
Other income0.260.670.690.51
Total expenses5.686.9810.089.86
Employee cost0.560.931.741.31
EBITDA0.956.141.846.07
EBITDA margin+14.3%+46.8%+15.4%+38.1%
Depreciation0.630.530.500.33
Interest0.550.540.450.39
Profit before tax0.035.741.585.86
Tax0.081.590.531.48
Net profit(0.05)4.151.054.38
Net profit margin-0.8%+31.6%+8.8%+27.5%
EPS (₹)(0.04)4.021.034.23
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital10.3410.3410.3410.34
Reserves & surplus8.898.934.783.69
Shareholders' funds (net worth)19.2319.2715.1214.03
Minority interest0.000.000.000.00
Secured loans2.122.761.882.03
Unsecured loans3.722.122.690.00
Total debt5.844.884.572.03
Total liabilities25.9925.0220.2316.13
Assets
Gross block7.006.986.004.38
Net block4.455.064.613.49
Capital work in progress0.140.140.140.12
Investments0.000.000.000.00
Inventories0.620.880.881.49
Sundry debtors6.094.813.251.78
Cash & bank balances6.965.995.774.85
Loans & advances4.661.521.602.31
Total current assets18.3313.2011.5010.43
Total current liabilities9.857.477.856.75
Net working capital8.485.733.653.68
Total assets25.9925.0220.2316.13
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash5.995.774.852.51
Net cash from operating activities0.270.702.225.79
Net cash from investing activities0.25(0.32)(0.94)(4.12)
Net cash from financing activities0.45(0.16)(0.37)0.67
Net change in cash0.970.220.912.34
Closing cash6.965.995.774.85
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth-49.5%+10.1%-25.2%-
EBITDA growth-84.5%+233.7%-69.7%-
PBT growth-99.5%+263.3%-73.0%+9997.0%
Net income growth-101.2%+295.2%-76.0%-
Revenue CAGR (3Y)-25.3%---
EBITDA CAGR (3Y)-46.1%---
Profitability & leverage
Net income margin-0.8%+31.6%+8.8%+27.5%
Return on capital employed+2.3%+27.8%+11.2%+38.7%
Return on net worth-0.2%+24.1%+7.3%+31.2%
Debt / equity0.280.270.230.14
Long-term debt / equity0.150.130.130.13
Interest cover171.889.6333.586.79
Efficiency & per share
Fixed asset turnover0.952.022.303.64
Inventory turnover8.8414.9110.0610.69
Debtors turnover1.223.264.748.95
EPS (₹)(0.04)4.021.034.23
Dividend per share (₹)0.000.000.000.00
Book value per share (₹)18.6018.6414.6213.56
ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue1.120.660.871.111.591.951.984.60
Revenue growth (YoY)-29.6%-66.2%-56.1%-75.9%-58.1%---
Other income0.090.090.15(0.24)0.160.160.170.18
Total expenses0.871.050.731.111.111.721.761.50
EBITDA0.25(0.39)0.140.000.480.230.223.10
EBITDA margin+22.3%-59.1%+16.1%0.0%+30.2%+11.8%+11.1%+67.4%
Depreciation0.110.110.110.110.120.120.120.07
Interest0.130.090.090.100.100.100.110.11
Profit before tax0.10(0.50)0.09(0.45)0.420.170.163.10
Tax(0.03)(0.04)0.030.020.040.020.060.91
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Revenue6.6313.1211.9215.9310.467.650.56
Revenue growth-49.5%+10.1%-25.2%+52.3%+36.7%+1266.1%-
Other income0.250.640.690.510.290.100.00
Total expenses5.686.929.889.867.355.560.37
Employee cost0.590.911.581.310.941.020.11
EBITDA0.956.202.046.073.112.090.19
EBITDA margin+14.3%+47.3%+17.1%+38.1%+29.7%+27.3%+33.9%
Depreciation0.470.460.500.330.290.260.02
Interest0.430.470.450.390.350.370.04
Profit before tax0.305.911.785.862.761.560.13
Tax0.141.610.531.480.740.440.03
Net profit0.164.301.254.382.021.120.10
Net profit margin+2.4%+32.8%+10.5%+27.5%+19.3%+14.6%+17.9%
EPS (₹)0.154.151.224.234.292.40240.96
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Equity & liabilities
Share capital10.3410.3410.3410.344.704.700.01
Reserves & surplus9.429.274.973.694.962.940.10
Shareholders' funds (net worth)19.7619.6115.3114.039.667.640.11
Secured loans1.672.281.882.030.740.840.77
Unsecured loans3.401.892.690.000.260.250.59
Total debt5.074.174.572.031.001.091.36
Total liabilities25.7524.6520.4216.1410.668.731.46
Assets
Gross block6.326.316.004.383.553.122.93
Net block4.004.464.613.492.992.842.91
Capital work in progress0.140.140.140.120.000.000.00
Investments0.110.110.110.110.000.000.00
Inventories0.620.880.881.491.020.860.84
Sundry debtors6.094.813.251.782.051.571.32
Cash & bank balances6.955.975.754.742.511.131.10
Loans & advances4.661.511.592.300.440.540.15
Total current assets18.3213.1711.4710.316.024.103.41
Total current liabilities9.637.257.816.744.653.476.35
Net working capital8.695.923.663.571.370.63(2.94)
Total assets25.7524.6520.4216.1410.668.731.46
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Opening cash5.975.754.742.511.121.030.00
Net cash from operating activities0.250.752.325.792.871.512.99
Net cash from investing activities0.230.33(0.94)(4.23)(1.10)(3.96)(2.92)
Net cash from financing activities0.49(0.86)(0.37)0.67(0.39)2.550.96
Net change in cash0.970.221.012.231.380.101.03
Closing cash6.955.975.754.742.511.131.10
ParticularsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Growth
Sales growth-49.5%+10.1%-25.2%+52.3%+36.7%+1266.1%-
EBITDA growth-84.7%+203.9%-66.4%+95.2%+48.8%+1000.0%-
PBT growth-94.9%+232.0%-69.6%+112.3%+76.9%+9997.0%+9997.0%
Net income growth-96.3%+244.0%-71.5%+116.8%+80.4%+1020.0%-
Revenue CAGR (3Y)-25.3%+7.9%+15.9%+205.3%---
EBITDA CAGR (3Y)-46.1%+25.9%-0.8%+217.3%---
Profitability & leverage
Net income margin+2.4%+32.8%+10.5%+27.5%+19.3%+14.6%+17.9%
Return on capital employed+2.9%+28.4%+12.3%+46.6%+32.1%+37.9%+29.6%
Return on net worth+0.8%+24.6%+8.6%+36.9%+23.4%+29.2%+218.2%
Debt / equity0.230.250.230.130.120.3112.27
Long-term debt / equity0.120.120.130.110.080.238.86
Interest cover89.588.1929.226.7912.4120.2223.53
Efficiency & per share
Fixed asset turnover1.052.132.304.023.142.530.46
Inventory turnover8.8414.9110.0612.6911.139.001.60
Debtors turnover1.223.264.748.325.785.291.02
EPS (₹)0.154.151.224.234.292.40240.96
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)19.1118.9714.8113.5720.5416.25110.40

To see the full year-wise statements and ratios of Gian Life Care Limited, buy the company report.

Board of directors of Gian Life Care Limited

Gian Life Care has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arun Kumar Gupta
Also directs: Gian Satguru Pathology LLP, Gian (Dras) Tradex Private Limited, Gian Path Lab (India) Private Limited
Managing Director06 Nov 20187 Years 11 MonthsCurrent
Rashika Agarwal
Also directs: Gian Satguru Pathology LLP, Gian (Dras) Tradex Private Limited, Gian Path Lab (India) Private Limited
Director06 Nov 20187 Years 11 MonthsCurrent
Abhiram Saran AgarwalAdditional Director25 Feb 20206 Years 8 MonthsCurrent
Umang GuptaAdditional Director25 Feb 20206 Years 8 MonthsCurrent
View all directors

Auditor

Gian Life Care Limited is audited by Sharp Aarth & Co. LLP for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Sharp Aarth & Co. LLPFY 2022132748W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 30.20%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 69.80%.

Promoters: 30.20%Retail & Others: 69.80%
Sep 2026
QUARTER
30.20% Promoters
69.80% Retail & Others
Promoter holding - history
Now 30.20% · Sep 2026High 32.10% · Dec 2025Low 30.20% · Sep 2026
29%30.3%31.5%32.8%34%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 32.10%Mar 2026: 32.10%Jun 2026: 32.10%Sep 2026: 30.20%32.10%30.20%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters30.20%32.10%32.10%32.10%
Public69.80%67.90%67.90%67.90%

Charges & borrowings

Open charges
₹3.88 Cr
Satisfied charges
None
Breakdown by lending institutions
Indian Bank₹3.88 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Mar 2022100569255Indian Bank₹1.8 CrOpen
31 Dec 2020100439476Indian Bank₹2.08 CrOpen

To see the full charge records of Gian Life Care Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Gian Life Care Limited has 87 deals on record (86 market trades, 1 ipo); the latest was in March 2026.

Total deals
87
Market trades
86
IPO
1

Deals on record (5 of 87)

WhenDealAmountParties
Sep 2024Market trade₹35 LakhBuyer: Jainam Broking Limited
Seller: an individual
Jul 2022Market trade₹46.3 LakhBuyer: Eventful Trading LLP , Cosmos Prime Projects Limited , an individual
Seller: Alpha Leon Enterprises LLP , 2 individuals
Jul 2022Market trade₹19.6 LakhBuyer: Alpha Leon Enterprises LLP
Jul 2022Market trade₹14.3 LakhBuyer: Alpha Leon Enterprises LLP
Seller: an individual
Jun 2022Market trade₹2.17 CrBuyer: Munish Kumar Huf, 3 individuals
Seller: Lalit Dua (Huf), Alpha Leon Enterprises LLP , 2 individuals

To see the full deal history of Gian Life Care Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gian Life Care Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Gian Life Care has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Gian Path Lab (India) Private LimitedU85100UP2021PTC157224

To see the full group structure of Gian Life Care Limited, buy the company report.

Employees & EPFO

Gian Life Care Limited has a workforce of 23 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
23
Active EPFO establishments
1

GST

No GST registration is on our record for Gian Life Care Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Gian Life Care Limited has 14 board changes on record since 2018: 9 appointments and 5 cessations. The latest: Sanjay Bhargava ceased to be CEO on 15 Apr 2022.

AGM
Gian Life Care Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Gian Life Care Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Uttar Pradesh I.
Ceased
Sanjay Bhargava ceased to be CEO.
Charges
A charge with Indian Bank amounted to Rs. 1.80 Cr with Charge ID 100569255 was registered on 28 Mar 2022.
Charges
A charge with Indian Bank of Rs. 2.08 Cr registered on 31 Dec 2020 with Charge ID 100439476 was modified on 30 Oct 2021.
Appointed
Sanjay Bhargava was appointed as CEO.
Charges
A charge with Indian Bank amounted to Rs. 2.08 Cr with Charge ID 100439476 was registered on 31 Dec 2020.
Ceased
Astha Chaturvedi ceased to be Company Secretary.
Appointed
Abhiram Saran Agarwal was appointed as Additional Director.
Appointed
Umang Gupta was appointed as Additional Director.
Ceased
Ashutosh Kumar Asthana ceased to be Director.
Ceased
Shashank Dwivedi ceased to be Additional Director.

8 earlier events are in the company report.

Frequently asked questions

Gian Life Care is an active public limited company based in Kanpur, Uttar Pradesh, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 06 November 2018 (8+ years old) and is registered under CIN L85100UP2018PLC110119. Listed on BSE: 542918.

Gian Life Care reported revenue of ₹6.63 Cr for FY 2024-25 (down 49.5% YoY) based on consolidated financials.

Gian Life Care has 4 current directors:

The latest financial statements of Gian Life Care on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.

The CIN (Corporate Identification Number) of Gian Life Care is L85100UP2018PLC110119. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Gian Life Care is a listed company as per MCA records. Its shares are listed on BSE (code: 542918).

Gian Life Care has 26 court cases on record: 2 filed by the company and 24 filed against it. 8 are pending. Most are in the district courts.

Gian Life Care was incorporated on 06 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Gian Life Care has 87 deals on record (86 market trades, 1 ipo); the latest was in March 2026.

Sanjay Bhargava ceased to be CEO on 15 Apr 2022. Sanjay Bhargava was appointed as CEO on 18 Oct 2021. Astha Chaturvedi ceased to be Company Secretary on 01 Jun 2020. Gian Life Care has 14 board changes on record in total.